Advertisement
Advertisement
U.S. markets close in 2 hours 26 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Mauna Kea Technologies SA (1MK.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.5110+0.0040 (+0.79%)
As of 08:01AM CEST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.5070
Open0.5110
Bid0.5070 x 0
Ask0.6120 x 0
Day's Range0.5110 - 0.5110
52 Week Range0.3605 - 0.8560
Volume500
Avg. Volume197
Market Cap24.379M
Beta (5Y Monthly)1.59
PE Ratio (TTM)N/A
EPS (TTM)-0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 1MK.F

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Business Wire

      Mauna Kea Technologies Announces the Coverage of Its Stock by Portzamparc – Groupe BNP Paribas

      PARIS & BOSTON, January 30, 2023--Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe and needle confocal laser endomicroscopy (p/nCLE) platform, today announces the coverage of its stock by Portzamparc – Groupe BNP Paribas.

    • Business Wire

      Mauna Kea Technologies Announces Sales for the Fourth Quarter and Full Year 2022

      PARIS & BOSTON, January 26, 2023--Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe and needle confocal laser endomicroscopy (p/nCLE) platform, today announces its fourth quarter and full year 2022 sales1.

    • Business Wire

      Mauna Kea Technologies Announces Its 2023 Financial Calendar

      PARIS & BOSTON, January 24, 2023--Regulatory News: Mauna Kea Technologies (Euronext: MKEA,) (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the publication of its 2023 Financial Calendar.

    Advertisement
    Advertisement